4
Changes in Ownership
TELA Bio, Inc. Filed Acc 0001062993-22-005778
Chief Strategic Officer acquired 12,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Talmo Paul Chief Strategic Officer | 2022-02-23 | Grant or award | +12,200 | 42,670 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Talmo Paul Chief Strategic Officer | 2022-02-23 | Grant or award · Stock Option (Right to Buy) | +20,900 | 20,900 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…